News
Genotype-guided warfarin appears safer
Genotype-guided warfarin dosing is safer than clinically guided dosing for patients undergoing elective hip or knee arthroplasty, according to a...
News
Representation in cancer clinical trials
ATLANTA—New research suggests some racial/ethnic minority groups are underrepresented in clinical trials for cancer patients in the US. African-...
News
Cancer patients want info about marijuana
A new study suggests cancer patients may be open to using marijuana, but healthcare providers may be falling short in educating patients on...
News
JAK inhibitors face off in myelofibrosis trial
Results of the SIMPLIFY-1 study revealed how 2 JAK inhibitors—momelotinib and ruxolitinib—compared to one another in myelofibrosis (MF) patients...
News
Carbohydrates appear key to malaria infection
Carbohydrates on the surface of malaria parasites play a critical role in the parasites’ ability to infect mosquito and human hosts, according to...
News
Cancer patients’ complaints about care
A new study suggests cancer patients may be more concerned with the human aspects of care than the technical ones. Researchers studied complaints...
News
How APL cells evade the immune system
New research has revealed a way in which acute promyelocytic leukemia (APL) cells evade destruction by the immune system. The study showed how...
News
EC expands approval of obinutuzumab in FL
The European Commission (EC) has expanded the marketing authorization for obinutuzumab (Gazyvaro). The drug is now approved for use in combination...
News
Combination ‘sets new standard’ for GVHD prophylaxis
A 2-drug combination sets a new standard for prevention of acute graft-versus-host disease (GVHD), according to an author of a new study. The...
News
SCD drug receives rare pediatric disease designation
The US Food and Drug Administration (FDA) has granted rare pediatric disease designation to Altemia™ soft gelatin capsules for the treatment of...
News
Antibiotic could help treat CML
The antibiotic tigecycline may enhance the treatment of chronic myeloid leukemia (CML), according to research published in Nature Medicine. ...
News
Midostaurin approved to treat AML, SM in Europe
The European Commission has approved the multi-targeted kinase inhibitor midostaurin (Rydapt®) to treat acute myeloid leukemia (AML) and 3 types...
News
ESC working groups publish consensus on DVT
Experts in Europe have published a consensus document on the diagnosis and management of acute deep vein thrombosis (DVT). The document provides...
News
FDA grants RMAT designation to HSCT adjunct
The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to ATIR101™, which is intended to...
News
Team creates guidelines on CAR T-cell-related toxicity
Researchers say they have created guidelines for managing the unique toxicities associated with chimeric antigen receptor (CAR) T-cell therapy....